PA
BTG icon

PharVision Advisers’s B2Gold BTG Stock Holding History

PharVision Advisers’s Portfolio BTG Stock Details BTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,064
Closed -$127K – 74
2026
Q1 		$127K Sell
28,064
-40,223
-59% -$202K 1.29% 26
2025
Q4 		$308K Buy
68,287
+31,980
+88% +$149K 0.16% 255
2025
Q3 		$180K Buy
+36,307
New +$143K 0.1% 538

Other funds holding BTG

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.97B AUM 43.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

PharVision Advisers's BTG Position: Q2 2026 in Review

PharVision Advisers sold out of B2Gold (BTG) in Q2 2026, closing a stake of 28,064 shares — an estimated $127K sold.

PharVision Advisers first reported a position in BTG in Q3 2025 and held it in 3 quarters. The position peaked at $308K in Q4 2025. 303 funds tracked by Wall St. Rank hold BTG as of Q2 2026.

  • PharVision Advisers reported no remaining B2Gold position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 28,064 B2Gold shares in Q2 2026, an estimated $127K.
  • PharVision Advisers first reported a position in B2Gold in Q3 2025 and held it in 3 quarters.
  • PharVision Advisers's B2Gold position peaked at $308K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held B2Gold as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.